Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells
Open Access
- 29 May 2020
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 8 (6) , 138
Abstract
The main aim of this study is to find a therapeutic compound to inhibit IL-6, not TNF-alpha and IL-1beta, in macrophage-like cells, because the high-levels of IL-6 production by macrophages are reported to cause unfavorable outcomes under several disease conditions (e.g., autoimmune diseases, and acute viral infections, including COVID-19). In this study, the potential effects of javamide-II on IL-6, IL-1beta and TNF-alpha productions were determined using their ELISA kits in macrophage-like THP-1 cells. Western blots were also performed using the same cells, to determine its effects on signaling pathways (ERK, p38, JNK, c-Fos, ATF-2, c-Jun and NF-κB p65). At concentrations of 0.2–40 µM, javamide-II inhibited IL-6 production significantly in the THP-1 cells (IC50 of 0.8 µM) (P < 0.02). However, javamide-II did not inhibit IL-1beta or TNF-alpha productions much at the same concentrations. In addition, the treatment of javamide-II decreased the phosphorylation of p38 without significant effects on ERK and JNK phosphorylations in the THP-1 cells. Furthermore, the p38 inhibition, followed by the reduction of ATF-2 phosphorylation (not c-Fos, c-Jun or NF-κB p65), led to the suppression of IL-6 mRNA expression in the cells (P < 0.02). The data indicate that javamide-II may be a potent compound to inhibit IL-6 production via suppressing the p38 signal pathway, without significant effects on the productions of TNF-alpha and IL-1beta in macrophage-like THP-1 cells.Keywords
Funding Information
- U.S. Department of Agriculture (1235-51000-054-00D)
This publication has 51 references indexed in Scilit:
- Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseasesAnnals of Medicine, 2013
- Targeting Interleukin-6 in Rheumatoid ArthritisDrugs, 2013
- Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitorEuropean Journal of Pharmacology, 2013
- Multiple Facets of NF-κB in the HeartCirculation Research, 2011
- Broccoli‐derived phytochemicals indole‐3‐carbinol and 3,3′‐diindolylmethane exerts concentration‐dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicalsMolecular Carcinogenesis, 2011
- Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocationEuropean Journal of Pharmacology, 2011
- The Impact of Chronic Inflammation on the Growing Skeleton: Lessons from Interleukin-6 Transgenic MiceHormone Research in Paediatrics, 2009
- NF- B as a Critical Link Between Inflammation and CancerCold Spring Harbor Perspectives in Biology, 2009
- MAPKs and their relevance to arthritis and inflammationRheumatology, 2007
- Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modesRheumatology, 2006